Earnings Call · Q2 FY2026·2026-08-05

Q2 26EPS -37.50%·Rev n/aQ1 26EPS +3.85%·Rev n/aQ4 25EPS -0.53%·Rev n/aQ3 25EPS -13.79%·Rev n/a⚠ consensus missing

Coherus Oncology, Inc. CHRS

Heidi — Operator

Carrie Graham — Operator (Conference Call Moderator (Investor Relations))

Denny Lanfear — Chief Executive Officer

Dr. Rosh Dias — Chief Medical Officer

Sameer Goregaoker — Chief Commercial Officer

Bryan McMichael — Chief Financial Officer

−12.8%1d on move date3d−14.5%5d−19.3%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CHRS calls or request research access.

More CHRS calls Browse calls Request research access